Renita Medical raises seed funding
January 2021 — Renita Medical Oy, a healthtech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.
Renita Medical is building a personalized brain health solution. The company’s AI-based software, the RENITA platform, uses a patient’s own functional brain activity and combines it with proven cognitive assessment tools to provide a comprehensive and objective report, from which doctors can base their neurological diagnosis. The platform will enhance the neurological diagnosis process and will offer an efficient way to monitor brain health.
Our role in the transaction
Oaklins’ team in Finland acted as the financial advisor in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more